HALDOL SOLUTAB Drug Patent Profile
✉ Email this page to a colleague
When do Haldol Solutab patents expire, and when can generic versions of Haldol Solutab launch?
Haldol Solutab is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.
The generic ingredient in HALDOL SOLUTAB is haloperidol. There are twenty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the haloperidol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Haldol Solutab
A generic version of HALDOL SOLUTAB was approved as haloperidol by MYLAN on June 10th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HALDOL SOLUTAB?
- What are the global sales for HALDOL SOLUTAB?
- What is Average Wholesale Price for HALDOL SOLUTAB?
Summary for HALDOL SOLUTAB
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 139 |
| Patent Applications: | 3,836 |
| DailyMed Link: | HALDOL SOLUTAB at DailyMed |
US Patents and Regulatory Information for HALDOL SOLUTAB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortho Mcneil Pharm | HALDOL SOLUTAB | haloperidol | TABLET;ORAL | 017079-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
